Resona Asset Management Co. Ltd. Has $69.99 Million Holdings in Axon Enterprise, Inc $AXON

Resona Asset Management Co. Ltd. lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 17.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 122,358 shares of the biotechnology company’s stock after purchasing an additional 18,506 shares during the period. Resona Asset Management Co. Ltd.’s holdings in Axon Enterprise were worth $69,988,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. NEOS Investment Management LLC lifted its holdings in Axon Enterprise by 82.7% in the third quarter. NEOS Investment Management LLC now owns 25,369 shares of the biotechnology company’s stock valued at $18,206,000 after buying an additional 11,482 shares during the period. Vanguard Group Inc. lifted its holdings in Axon Enterprise by 4.2% in the third quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock valued at $6,684,217,000 after buying an additional 376,904 shares during the period. Legal & General Group Plc lifted its holdings in Axon Enterprise by 3.1% in the third quarter. Legal & General Group Plc now owns 421,114 shares of the biotechnology company’s stock valued at $302,208,000 after buying an additional 12,736 shares during the period. Wealth Enhancement Advisory Services LLC lifted its holdings in Axon Enterprise by 93.1% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 23,365 shares of the biotechnology company’s stock valued at $13,270,000 after buying an additional 11,262 shares during the period. Finally, BIT Capital GmbH lifted its holdings in Axon Enterprise by 75.6% in the third quarter. BIT Capital GmbH now owns 3,535 shares of the biotechnology company’s stock valued at $2,537,000 after buying an additional 1,522 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insiders Place Their Bets

In other Axon Enterprise news, insider Isaiah Fields sold 2,000 shares of the company’s stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $535.01, for a total value of $1,070,020.00. Following the completion of the sale, the insider directly owned 55,588 shares of the company’s stock, valued at approximately $29,740,135.88. This represents a 3.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $500.24, for a total transaction of $5,002,400.00. Following the completion of the sale, the chief executive officer directly owned 3,090,997 shares of the company’s stock, valued at $1,546,240,339.28. The trade was a 0.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 13,855 shares of company stock worth $7,109,828 in the last ninety days. 4.20% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

AXON has been the subject of several research analyst reports. Robert W. Baird set a $800.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 25th. Barclays decreased their price target on shares of Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating for the company in a research note on Friday, May 8th. Citigroup reaffirmed a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, February 25th. Morgan Stanley set a $600.00 price target on Axon Enterprise in a report on Thursday, May 7th. Finally, TD Cowen cut their price target on Axon Enterprise from $950.00 to $825.00 and set a “buy” rating on the stock in a report on Wednesday, April 8th. Sixteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus price target of $712.75.

Axon Enterprise Trading Up 1.9%

Shares of AXON stock opened at $399.37 on Tuesday. Axon Enterprise, Inc has a 52-week low of $339.01 and a 52-week high of $885.91. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. The company has a 50-day simple moving average of $428.80 and a two-hundred day simple moving average of $511.32. The company has a market capitalization of $32.19 billion, a price-to-earnings ratio of 160.39, a PEG ratio of 9.22 and a beta of 1.44.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The business had revenue of $807.35 million during the quarter, compared to the consensus estimate of $778.91 million. During the same period in the prior year, the firm posted $1.47 EPS. The firm’s quarterly revenue was up 33.7% compared to the same quarter last year. Research analysts anticipate that Axon Enterprise, Inc will post 1.41 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.